e-Edition
Obituaries
Photo Gallery
Magazines
News Crew
Paywall Login
Login to Comment
Register
December 15th, 2015
Menu
Home
News
Sports
Business
Entertainment
Federal Election
Classifieds
Life
Commentary
Contact
Local News
Provincial News
National News
World News
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
Nasdaq Composite
Standard & Poors 500
New York Composite
Gold
Crude Oil
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries
20+ Year Treas Bond Ishares ETF
(NQ:
TLT
)
151.84
USD
+0.62 (+0.41%)
Streaming Delayed Price
Updated: 3:01 PM EST, Jan 15, 2021
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press releases about 20+ Year Treas Bond Ishares ETF
< Previous
1
2
Next >
Theralase Completes GMP Manufacture of Lead Drug
September 08, 2015
Tags
Business & Professional Services
Product Announcements
From
ACCESSWIRE
Theralase Demonstrates Stability of Lead Drug
September 04, 2015
Tags
Business & Professional Services
Product Announcements
From
ACCESSWIRE
Theralase Expands Photo Dynamic Compound Pipeline
September 03, 2015
Tags
Company Update
Business & Professional Services
From
ACCESSWIRE
Theralase Releases 2Q2015 Financials
August 27, 2015
Tags
Business & Professional Services
Earnings
From
ACCESSWIRE
Theralase Provides Corporate Update
August 17, 2015
Tags
Business & Professional Services
From
ACCESSWIRE
Theralase Achieves 98% Destruction of Bladder Cancer
July 22, 2015
Tags
Product Announcements
Business & Professional Services
From
ACCESSWIRE
Theralase Appoints Experienced Sales and Marketing Team to Launch Next Generation Therapeutic Laser
July 17, 2015
Tags
Management Changes
Business & Professional Services
From
ACCESSWIRE
Theralase Appoints Director of Investor Relations
July 16, 2015
Tags
Business & Professional Services
Management Changes
From
ACCESSWIRE
Theralase to Present at BIO Conference
June 18, 2015
Tags
Business & Professional Services
Conferences
From
ACCESSWIRE
Theralase Releases Next Generation Therapeutic Laser to Select Healthcare Practitioners and Sales Team
June 11, 2015
Tags
Business & Professional Services
Regulatory
From
ACCESSWIRE
Next Generation Therapeutic Laser Receives Safety Approval
June 10, 2015
Tags
Business & Professional Services
From
ACCESSWIRE
Theralase Increases Revenue 2% in Q1 2015 Financials
May 28, 2015
Tags
Earnings
Business & Professional Services
From
ACCESSWIRE
Theralase Grants Stock Options
May 28, 2015
Tags
Regulatory
Business & Professional Services
From
ACCESSWIRE
Theralase Presents Latest Scientific Research at 15th International Photodynamic Association World Congress
May 27, 2015
Tags
Business & Professional Services
Conferences
From
ACCESSWIRE
Theralase to Present at the 2015 Marcum Microcap Conference
May 26, 2015
Tags
Business & Professional Services
From
ACCESSWIRE
Theralase Manufactures High Purity Anti-Cancer Drug
May 12, 2015
Tags
Product Announcements
Business & Professional Services
From
ACCESSWIRE
Theralase Increases Revenue 15% in 2014 Financials
May 01, 2015
Tags
Business & Professional Services
From
ACCESSWIRE
Theralase Manufactures First Pre-Commercial Batch of Lead Anti-Cancer Drug
April 09, 2015
Tags
Business & Professional Services
From
ACCESSWIRE
Theralase Holds pre-CTA Meeting with Health Canada
April 02, 2015
Tags
Business & Professional Services
From
ACCESSWIRE
Theralase Partners with CiToxLAB for Toxicology
March 23, 2015
Tags
Business & Professional Services
From
ACCESSWIRE
iShares Fixed Income ETFs Are First to Be Analyzed on Bloomberg Yield and Spread Analysis Tool
November 27, 2012
From
Business Wire News Releases
Wall Street Media Presents Wells Fargo Securities: Are Treasuries No Longer a “Safe Haven?”
November 10, 2011
From
Business Wire News Releases
Theralase Technologies Inc. Announces its Year End Financial Results
May 02, 2011
From
Marketwired
Theralase Launches New Medical Laser Marketing Program
March 14, 2011
From
Marketwired
Zacks' Voice of the People Highlights Opportunities with iShares Barclays 20+ Year Treasury Bond, iPath S&P 500 VIX Short-Term Futures ETN, Delta Airlines, United Continental Holdings and AMR
March 11, 2011
From
PR Newswire
Theralase Appoints Chief Scientific Officer
February 14, 2011
From
Marketwired
Theralase Receives Approval for Product Sales Into Europe
January 31, 2011
From
Marketwired
Theralase Closes Equity Financing
January 07, 2011
From
Marketwired
Theralase Increases Size of Private Placement Offering
December 29, 2010
From
Marketwired
Theralase Achieves Success in Destruction of Listeria Bacteria
December 15, 2010
From
Marketwired
< Previous
1
2
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.